Private Advisory Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
MCMU
Private Advisory Group's RXRX Position: Q2 2026 in Review
Private Advisory Group reduced its Recursion Pharmaceuticals (RXRX) stake by 28% in Q2 2026, selling an estimated $192K and leaving 146,310 shares worth $537K. The position accounts for 0.03% of the portfolio, ranked #218.
Private Advisory Group first reported a position in RXRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $626K in Q1 2026. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- Private Advisory Group held 146,310 shares of Recursion Pharmaceuticals worth $537K as of Q2 2026.
- Private Advisory Group sold 57,730 Recursion Pharmaceuticals shares in Q2 2026, an estimated $192K.
- Recursion Pharmaceuticals made up 0.03% of Private Advisory Group's portfolio in Q2 2026, its #218 holding.
- Private Advisory Group first reported a position in Recursion Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Private Advisory Group's Recursion Pharmaceuticals position peaked at $626K in Q1 2026.
- 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.